(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of VLDLR mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Vldlr (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VLDLR mRNA CTD PMID:36331819 1,2-dichloroethane increases expression ISO Vldlr (Mus musculus) 6480464 ethylene dichloride results in increased expression of VLDLR mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Vldlr (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of VLDLR mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression ISO Vldlr (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of VLDLR mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of VLDLR mRNA CTD PMID:12075121 and PMID:15901920 17beta-estradiol multiple interactions ISO VLDLR (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of VLDLR mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO VLDLR (Homo sapiens) 6480464 Estradiol results in decreased expression of VLDLR mRNA CTD PMID:31614463 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of VLDLR mRNA CTD PMID:36931579 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VLDLR mRNA and Fulvestrant inhibits the reaction [Estradiol results in increased expression of VLDLR mRNA] CTD PMID:32741896 and PMID:36931579 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VLDLR mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO VLDLR (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of VLDLR mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Vldlr (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl increases expression ISO VLDLR (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO VLDLR (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of VLDLR mRNA and Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] CTD PMID:11007951 and PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VLDLR mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Vldlr (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA CTD PMID:16120747 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Vldlr (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of VLDLR mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Vldlr (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Vldlr (Mus musculus) 6480464 AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to VLDLR gene] CTD PMID:15034205 and PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO VLDLR (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA CTD PMID:11007951 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO VLDLR (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2-hydroxypropanoic acid decreases expression ISO VLDLR (Homo sapiens) 6480464 Lactic Acid results in decreased expression of VLDLR mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of VLDLR mRNA CTD PMID:19643169 3,3',5,5'-tetrabromobisphenol A increases expression ISO VLDLR (Homo sapiens) 6480464 tetrabromobisphenol A results in increased expression of VLDLR mRNA CTD PMID:25424538 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of VLDLR protein CTD PMID:34915118 4,4'-diaminodiphenylmethane affects expression ISO Vldlr (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane affects the expression of VLDLR mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of VLDLR mRNA CTD PMID:30723492 4-hydroxyphenyl retinamide decreases expression ISO Vldlr (Mus musculus) 6480464 Fenretinide results in decreased expression of VLDLR mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of VLDLR mRNA CTD PMID:31068541 7,12-dimethyltetraphene increases expression ISO Vldlr (Mus musculus) 6480464 9 more ... CTD PMID:32553695 8-Br-cAMP decreases expression ISO VLDLR (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VLDLR mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of VLDLR mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of VLDLR mRNA CTD PMID:28959563 acrylamide increases expression ISO VLDLR (Homo sapiens) 6480464 Acrylamide results in increased expression of VLDLR mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of VLDLR mRNA CTD PMID:23630614 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of VLDLR mRNA CTD PMID:24977338 all-trans-retinoic acid decreases expression ISO VLDLR (Homo sapiens) 6480464 Tretinoin results in decreased expression of VLDLR mRNA CTD PMID:33167477 all-trans-retinoic acid increases expression ISO VLDLR (Homo sapiens) 6480464 Tretinoin results in increased expression of VLDLR mRNA CTD PMID:21934132 and PMID:23830798 AM-251 increases expression ISO VLDLR (Homo sapiens) 6480464 AM 251 results in increased expression of VLDLR mRNA CTD PMID:16500647 amiodarone decreases expression ISO Vldlr (Mus musculus) 6480464 Amiodarone results in decreased expression of VLDLR mRNA CTD PMID:28962527 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of VLDLR mRNA CTD PMID:16483693 ampicillin decreases expression ISO VLDLR (Homo sapiens) 6480464 Ampicillin results in decreased expression of VLDLR mRNA CTD PMID:21632981 androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of VLDLR mRNA CTD PMID:25607892 antirheumatic drug increases expression ISO VLDLR (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of VLDLR mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO VLDLR (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of VLDLR mRNA CTD PMID:33212167 arsenite(3-) affects expression ISO VLDLR (Homo sapiens) 6480464 arsenite affects the expression of VLDLR mRNA CTD PMID:22959463 arsenous acid increases expression ISO VLDLR (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of VLDLR mRNA CTD PMID:20458559 more ... benzo[a]pyrene increases expression ISO Vldlr (Mus musculus) 6480464 Benzo(a)pyrene metabolite results in increased expression of VLDLR mRNA and Benzo(a)pyrene results in increased expression of VLDLR mRNA CTD PMID:19770486 more ... benzo[a]pyrene decreases expression ISO Vldlr (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of VLDLR mRNA CTD PMID:15034205 and PMID:22228805 benzo[a]pyrene multiple interactions ISO Vldlr (Mus musculus) 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of VLDLR mRNA] CTD PMID:15034205 benzo[a]pyrene decreases expression ISO VLDLR (Homo sapiens) 6480464 Benzo(a)pyrene metabolite results in decreased expression of VLDLR mRNA and Benzo(a)pyrene results in decreased expression of VLDLR mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO VLDLR (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 bilirubin IXalpha decreases expression ISO VLDLR (Homo sapiens) 6480464 Bilirubin results in decreased expression of VLDLR mRNA CTD PMID:20196124 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of VLDLR mRNA CTD PMID:25607892 bisphenol A increases expression ISO VLDLR (Homo sapiens) 6480464 bisphenol A results in increased expression of VLDLR mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VLDLR mRNA CTD PMID:12075121 more ... Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of VLDLR mRNA CTD PMID:25607892 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of VLDLR mRNA CTD PMID:33453195 carbamazepine affects expression ISO VLDLR (Homo sapiens) 6480464 Carbamazepine affects the expression of VLDLR mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Vldlr (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 carmustine affects response to substance ISO VLDLR (Homo sapiens) 6480464 VLDLR mRNA affects the susceptibility to Carmustine CTD PMID:16365179 casticin decreases expression ISO Vldlr (Mus musculus) 6480464 casticin results in decreased expression of VLDLR mRNA CTD PMID:28444820 CGP 52608 multiple interactions ISO VLDLR (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to VLDLR gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO Vldlr (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of VLDLR mRNA CTD PMID:32715474 chlorpyrifos increases expression ISO VLDLR (Homo sapiens) 6480464 Chlorpyrifos results in increased expression of VLDLR mRNA CTD PMID:25424538 choline multiple interactions ISO Vldlr (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of VLDLR mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VLDLR mRNA CTD PMID:20938992 and PMID:29127188 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of VLDLR mRNA CTD PMID:22023808 cisplatin increases expression ISO VLDLR (Homo sapiens) 6480464 Cisplatin results in increased expression of VLDLR mRNA CTD PMID:27594783 clofibrate increases expression ISO Vldlr (Mus musculus) 6480464 Clofibrate results in increased expression of VLDLR mRNA CTD PMID:17585979 and PMID:23811191 cobalt atom multiple interactions ISO VLDLR (Homo sapiens) 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of VLDLR mRNA CTD PMID:20105288 cobalt dichloride increases expression ISO VLDLR (Homo sapiens) 6480464 cobaltous chloride results in increased expression of VLDLR mRNA CTD PMID:19376846 more ... copper atom multiple interactions ISO VLDLR (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of VLDLR mRNA CTD PMID:20971185 copper(0) multiple interactions ISO VLDLR (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of VLDLR mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO VLDLR (Homo sapiens) 6480464 Copper Sulfate results in increased expression of VLDLR mRNA CTD PMID:19549813 cycloheximide multiple interactions ISO VLDLR (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] CTD PMID:11007951 cyclophosphamide decreases expression ISO VLDLR (Homo sapiens) 6480464 Cyclophosphamide metabolite results in decreased expression of VLDLR mRNA CTD PMID:24356939 cyclosporin A affects expression ISO VLDLR (Homo sapiens) 6480464 Cyclosporine affects the expression of VLDLR mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO VLDLR (Homo sapiens) 6480464 Cyclosporine results in decreased expression of VLDLR mRNA CTD PMID:32253466 cyclosporin A increases expression ISO VLDLR (Homo sapiens) 6480464 Cyclosporine results in increased expression of VLDLR mRNA CTD PMID:21632981 more ... cypermethrin increases expression ISO VLDLR (Homo sapiens) 6480464 cypermethrin results in increased expression of VLDLR mRNA CTD PMID:25424538 dexamethasone increases expression ISO Vldlr (Mus musculus) 6480464 Dexamethasone results in increased expression of VLDLR mRNA CTD PMID:22733784 diarsenic trioxide increases expression ISO VLDLR (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of VLDLR mRNA CTD PMID:20458559 more ... diazinon increases expression ISO VLDLR (Homo sapiens) 6480464 Diazinon results in increased expression of VLDLR mRNA CTD PMID:24356939 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of VLDLR mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO Vldlr (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of VLDLR mRNA CTD PMID:28962523 diclofenac decreases expression ISO Vldlr (Mus musculus) 6480464 Diclofenac results in decreased expression of VLDLR mRNA CTD PMID:26934552 dimethylarsinous acid increases expression ISO VLDLR (Homo sapiens) 6480464 dimethylarsinous acid results in increased expression of VLDLR mRNA CTD PMID:23487506 dioxygen increases expression ISO Vldlr (Mus musculus) 6480464 Oxygen deficiency results in increased expression of VLDLR mRNA CTD PMID:20880076 and PMID:24205000 dioxygen increases expression ISO VLDLR (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of VLDLR mRNA CTD PMID:24236059 and PMID:26516004 disodium selenite increases expression ISO VLDLR (Homo sapiens) 6480464 Sodium Selenite results in increased expression of VLDLR mRNA CTD PMID:24383545 diuron increases expression EXP 6480464 Diuron results in increased expression of VLDLR mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO VLDLR (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VLDLR mRNA CTD PMID:27188386 doxorubicin decreases expression ISO VLDLR (Homo sapiens) 6480464 Doxorubicin results in decreased expression of VLDLR mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of VLDLR mRNA CTD PMID:29391264 entinostat decreases expression ISO VLDLR (Homo sapiens) 6480464 entinostat results in decreased expression of VLDLR mRNA CTD PMID:27188386 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of VLDLR mRNA CTD PMID:25607892 epoxiconazole decreases expression ISO Vldlr (Mus musculus) 6480464 epoxiconazole results in decreased expression of VLDLR mRNA CTD PMID:35436446 ethanol decreases expression ISO Vldlr (Mus musculus) 6480464 Ethanol results in decreased expression of VLDLR mRNA CTD PMID:22173916 and PMID:29018328 ethanol increases expression ISO Vldlr (Mus musculus) 6480464 Ethanol results in increased expression of VLDLR mRNA CTD PMID:19167417 ethanol multiple interactions ISO Vldlr (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of VLDLR mRNA more ... CTD PMID:22173916 more ... fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of VLDLR mRNA CTD PMID:30307764 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of VLDLR protein CTD PMID:19359144 fluoxetine increases expression ISO VLDLR (Homo sapiens) 6480464 Fluoxetine results in increased expression of VLDLR mRNA CTD PMID:24356939 flutamide increases expression ISO Vldlr (Mus musculus) 6480464 Flutamide analog results in increased expression of VLDLR mRNA and Flutamide results in increased expression of VLDLR mRNA CTD PMID:17702527 folic acid multiple interactions ISO Vldlr (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of VLDLR mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VLDLR mRNA CTD PMID:20938992 and PMID:29127188 fonofos increases methylation ISO VLDLR (Homo sapiens) 6480464 Fonofos results in increased methylation of VLDLR promoter CTD PMID:22847954 formaldehyde increases expression ISO VLDLR (Homo sapiens) 6480464 Formaldehyde results in increased expression of VLDLR mRNA CTD PMID:27664576 fructose multiple interactions ISO Vldlr (Mus musculus) 6480464 [PPARD mRNA results in decreased susceptibility to Fructose] which results in decreased expression of VLDLR mRNA more ... CTD PMID:29289645 fulvestrant multiple interactions EXP 6480464 Fulvestrant inhibits the reaction [Estradiol results in increased expression of VLDLR mRNA] CTD PMID:36931579 furan increases expression EXP 6480464 furan results in increased expression of VLDLR mRNA CTD PMID:25539665 and PMID:27387713 furan decreases methylation EXP 6480464 furan results in decreased methylation of VLDLR gene CTD PMID:27387713 gamma-hexachlorocyclohexane increases expression ISO VLDLR (Homo sapiens) 6480464 Hexachlorocyclohexane results in increased expression of VLDLR mRNA CTD PMID:24356939 geldanamycin multiple interactions EXP 6480464 geldanamycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] CTD PMID:15808840 gemcitabine increases expression ISO VLDLR (Homo sapiens) 6480464 Gemcitabine results in increased expression of VLDLR mRNA CTD PMID:17039268 genistein increases expression EXP 6480464 Genistein results in increased expression of VLDLR mRNA CTD PMID:12075121 genistein increases expression ISO Vldlr (Mus musculus) 6480464 Genistein results in increased expression of VLDLR mRNA CTD PMID:24967385 geraniol increases expression ISO Vldlr (Mus musculus) 6480464 geraniol results in increased expression of VLDLR mRNA CTD PMID:26141755 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of VLDLR protein CTD PMID:19359144 herbimycin multiple interactions EXP 6480464 herbimycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] CTD PMID:15808840 hexaconazole increases expression ISO Vldlr (Mus musculus) 6480464 hexaconazole results in increased expression of VLDLR mRNA CTD PMID:22045034 hydrogen peroxide affects expression ISO VLDLR (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of VLDLR mRNA CTD PMID:20044591 hydroquinone increases expression ISO VLDLR (Homo sapiens) 6480464 hydroquinone results in increased expression of VLDLR mRNA CTD PMID:31256213 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of VLDLR mRNA CTD PMID:25972201 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of VLDLR mRNA CTD PMID:20097248 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of VLDLR mRNA CTD PMID:37077353 L-methionine multiple interactions ISO Vldlr (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of VLDLR mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VLDLR mRNA CTD PMID:20938992 and PMID:29127188 lead diacetate increases expression ISO Vldlr (Mus musculus) 6480464 lead acetate results in increased expression of VLDLR mRNA CTD PMID:25270620 methamphetamine increases expression ISO Vldlr (Mus musculus) 6480464 Methamphetamine results in increased expression of VLDLR mRNA CTD PMID:26307267 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of VLDLR mRNA CTD PMID:30467583 methotrexate affects expression ISO Vldlr (Mus musculus) 6480464 Methotrexate affects the expression of VLDLR mRNA CTD PMID:18502557 methylisothiazolinone decreases expression ISO VLDLR (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in decreased expression of VLDLR mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO VLDLR (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of VLDLR mRNA CTD PMID:28001369 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of VLDLR mRNA CTD PMID:25972201 mono(2-ethylhexyl) phthalate increases expression ISO VLDLR (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of VLDLR mRNA CTD PMID:24356939 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of VLDLR mRNA CTD PMID:21515302 nickel atom decreases expression ISO VLDLR (Homo sapiens) 6480464 Nickel results in decreased expression of VLDLR mRNA CTD PMID:25583101 nickel dichloride increases expression ISO VLDLR (Homo sapiens) 6480464 nickel chloride results in increased expression of VLDLR mRNA CTD PMID:17312168 nickel sulfate decreases expression ISO VLDLR (Homo sapiens) 6480464 nickel sulfate results in decreased expression of VLDLR mRNA CTD PMID:22714537 ochratoxin A decreases expression ISO VLDLR (Homo sapiens) 6480464 ochratoxin A results in decreased expression of VLDLR mRNA CTD PMID:24356939 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of VLDLR protein CTD PMID:19359144 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of VLDLR mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of VLDLR mRNA CTD PMID:25729387 ozone multiple interactions ISO Vldlr (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of VLDLR mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of VLDLR mRNA CTD PMID:27106289 and PMID:34911549 paracetamol affects expression ISO Vldlr (Mus musculus) 6480464 Acetaminophen affects the expression of VLDLR mRNA CTD PMID:15030884 and PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of VLDLR mRNA CTD PMID:33387578 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of VLDLR mRNA CTD PMID:25607892 parathion increases methylation ISO VLDLR (Homo sapiens) 6480464 Parathion results in increased methylation of VLDLR promoter CTD PMID:22847954 perfluorooctane-1-sulfonic acid decreases expression ISO VLDLR (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of VLDLR mRNA CTD PMID:32253466 perfluorooctane-1-sulfonic acid multiple interactions ISO Vldlr (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VLDLR mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of VLDLR mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of VLDLR mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO VLDLR (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of VLDLR mRNA CTD PMID:32253466 perfluorooctanoic acid increases expression ISO VLDLR (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of VLDLR mRNA CTD PMID:25868421 perfluorooctanoic acid increases expression ISO Vldlr (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of VLDLR mRNA CTD PMID:17681415 more ... phenobarbital multiple interactions ISO Vldlr (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of VLDLR mRNA] CTD PMID:19482888 phenobarbital affects expression ISO Vldlr (Mus musculus) 6480464 Phenobarbital affects the expression of VLDLR mRNA CTD PMID:19136022 and PMID:23091169 phenobarbital increases expression ISO Vldlr (Mus musculus) 6480464 Phenobarbital results in increased expression of VLDLR mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO VLDLR (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of VLDLR mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO VLDLR (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VLDLR mRNA CTD PMID:27188386 pioglitazone increases expression ISO Vldlr (Mus musculus) 6480464 pioglitazone results in increased expression of VLDLR mRNA CTD PMID:19706614 pioglitazone increases expression ISO VLDLR (Homo sapiens) 6480464 Pioglitazone results in increased expression of VLDLR mRNA CTD PMID:30031879 pirinixic acid multiple interactions ISO VLDLR (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VLDLR mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Vldlr (Mus musculus) 6480464 pirinixic acid results in increased expression of VLDLR mRNA CTD PMID:17426115 more ... pirinixic acid multiple interactions ISO Vldlr (Mus musculus) 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of VLDLR mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of VLDLR mRNA] CTD PMID:17950772 and PMID:20813756 pirinixic acid affects expression ISO Vldlr (Mus musculus) 6480464 pirinixic acid affects the expression of VLDLR mRNA CTD PMID:19136022 potassium chromate decreases expression ISO VLDLR (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of VLDLR mRNA CTD PMID:22714537 prednisolone increases expression ISO VLDLR (Homo sapiens) 6480464 Prednisolone results in increased expression of VLDLR mRNA CTD PMID:24356939 pregnenolone 16alpha-carbonitrile decreases expression ISO Vldlr (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of VLDLR mRNA CTD PMID:28903501 prothioconazole increases expression ISO VLDLR (Homo sapiens) 6480464 prothioconazole results in increased expression of VLDLR mRNA CTD PMID:35048155 quercetin decreases expression ISO VLDLR (Homo sapiens) 6480464 Quercetin results in decreased expression of VLDLR mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO VLDLR (Homo sapiens) 6480464 Lactic Acid results in decreased expression of VLDLR mRNA CTD PMID:30851411 radicicol multiple interactions EXP 6480464 monorden inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] CTD PMID:15808840 rimonabant multiple interactions ISO Vldlr (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of VLDLR mRNA] CTD PMID:19030233 rotenone increases expression ISO Vldlr (Mus musculus) 6480464 Rotenone results in increased expression of VLDLR mRNA CTD PMID:17702527 SB 431542 multiple interactions ISO VLDLR (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VLDLR mRNA CTD PMID:27188386 silver atom increases expression ISO VLDLR (Homo sapiens) 6480464 Silver results in increased expression of VLDLR mRNA CTD PMID:26014281 silver(0) increases expression ISO VLDLR (Homo sapiens) 6480464 Silver results in increased expression of VLDLR mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO VLDLR (Homo sapiens) 6480464 sodium arsenite results in decreased expression of VLDLR mRNA and sodium arsenite results in decreased expression of VLDLR protein CTD PMID:21925251 and PMID:22714537 streptozocin multiple interactions ISO Vldlr (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of VLDLR mRNA CTD PMID:29127188 succimer multiple interactions ISO VLDLR (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VLDLR mRNA CTD PMID:26378955 sunitinib increases expression ISO VLDLR (Homo sapiens) 6480464 Sunitinib results in increased expression of VLDLR mRNA CTD PMID:31533062 tamoxifen affects expression ISO Vldlr (Mus musculus) 6480464 Tamoxifen affects the expression of VLDLR mRNA CTD PMID:17555576 temozolomide affects response to substance ISO VLDLR (Homo sapiens) 6480464 VLDLR mRNA affects the susceptibility to temozolomide CTD PMID:16365179 terbufos increases methylation ISO VLDLR (Homo sapiens) 6480464 terbufos results in increased methylation of VLDLR promoter CTD PMID:22847954 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of VLDLR mRNA CTD PMID:21515302 testosterone increases expression ISO Vldlr (Mus musculus) 6480464 Testosterone results in increased expression of VLDLR mRNA CTD PMID:20403060 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VLDLR mRNA CTD PMID:32741896 testosterone decreases expression ISO Vldlr (Mus musculus) 6480464 Testosterone results in decreased expression of VLDLR mRNA CTD PMID:20403060 and PMID:20844152 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of VLDLR mRNA and Carbon Tetrachloride results in increased expression of VLDLR protein CTD PMID:12629582 and PMID:31150632 tetrachloromethane multiple interactions ISO Vldlr (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of VLDLR mRNA CTD PMID:30517762 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of VLDLR mRNA] CTD PMID:31150632 titanium dioxide decreases expression ISO Vldlr (Mus musculus) 6480464 titanium dioxide results in decreased expression of VLDLR mRNA CTD PMID:23557971 and PMID:29264374 titanium dioxide affects expression ISO Vldlr (Mus musculus) 6480464 titanium dioxide affects the expression of VLDLR mRNA CTD PMID:17656681 topotecan increases expression EXP 6480464 Topotecan results in increased expression of VLDLR mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of VLDLR mRNA CTD PMID:25729387 Tributyltin oxide increases expression ISO Vldlr (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased expression of VLDLR mRNA CTD PMID:25270620 trichloroethene increases expression ISO Vldlr (Mus musculus) 6480464 Trichloroethylene results in increased expression of VLDLR mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of VLDLR mRNA CTD PMID:33387578 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of VLDLR gene CTD PMID:27618143 trichostatin A decreases expression ISO VLDLR (Homo sapiens) 6480464 trichostatin A results in decreased expression of VLDLR mRNA CTD PMID:24935251 triclosan decreases expression ISO VLDLR (Homo sapiens) 6480464 Triclosan results in decreased expression of VLDLR mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO Vldlr (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of VLDLR mRNA CTD PMID:19042947 triptonide decreases expression ISO Vldlr (Mus musculus) 6480464 triptonide results in decreased expression of VLDLR mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of VLDLR mRNA CTD PMID:21515302 Tungsten carbide multiple interactions ISO VLDLR (Homo sapiens) 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of VLDLR mRNA CTD PMID:20105288 tunicamycin multiple interactions ISO Vldlr (Mus musculus) 6480464 [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of VLDLR mRNA more ... CTD PMID:29289645 tunicamycin increases expression ISO VLDLR (Homo sapiens) 6480464 Tunicamycin results in increased expression of VLDLR mRNA and Tunicamycin results in increased expression of VLDLR protein CTD PMID:29289645 tunicamycin multiple interactions ISO VLDLR (Homo sapiens) 6480464 FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA] and FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein] CTD PMID:29289645 tunicamycin increases expression ISO Vldlr (Mus musculus) 6480464 Tunicamycin results in increased expression of VLDLR mRNA and Tunicamycin results in increased expression of VLDLR protein CTD PMID:29289645 urethane affects expression ISO VLDLR (Homo sapiens) 6480464 Urethane affects the expression of VLDLR mRNA CTD PMID:28818685 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of VLDLR mRNA and Valproic Acid results in decreased expression of VLDLR protein CTD PMID:19359144 valproic acid decreases expression ISO VLDLR (Homo sapiens) 6480464 Valproic Acid results in decreased expression of VLDLR mRNA CTD PMID:27188386 valproic acid increases expression ISO VLDLR (Homo sapiens) 6480464 Valproic Acid results in increased expression of VLDLR mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO Vldlr (Mus musculus) 6480464 Valproic Acid results in increased expression of VLDLR mRNA CTD PMID:22045034 vancomycin increases expression ISO Vldlr (Mus musculus) 6480464 Vancomycin results in increased expression of VLDLR mRNA CTD PMID:18930951 vorinostat decreases expression ISO VLDLR (Homo sapiens) 6480464 vorinostat results in decreased expression of VLDLR mRNA CTD PMID:27188386 zearalenone increases expression ISO VLDLR (Homo sapiens) 6480464 Zearalenone results in increased expression of VLDLR mRNA CTD PMID:25424538